Creating therapies for Alzheimer's disease by targeting neural circuits

Wednesday, November 9, 2016 - 18:31 in Health & Medicine

Age-related dementia will affect 10 percent of people in the U.S. within their lifetime. Alzheimer’s disease, the most prevalent type of dementia — and one for which there is no effective treatment or cure — causes a progressive and devastating loss of memory and cognition. For the past 25 years, efforts to develop a treatment for the disease have focused on the so-called “amyloid cascade hypothesis.” This proposes that amyloid-β (Aβ) peptides build up and clump together to form plaques in the brain, creating a cascade effect that ultimately leads to neuronal death and cognitive dysfunction. However, despite evidence of a link between amyloid-β and Alzheimer’s disease, efforts to target the peptide have so far failed to reverse this cognitive decline. Now, in a review paper published in the journal Nature, researchers at the Picower Institute for Learning and Memory at MIT argue that while elevated amyloid-β levels may initiate the sequence of events that...

Read the whole article on MIT Research

More from MIT Research

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net